Alfa Cytology

Alfa Cytology is a specialized contract research organization (CRO) that provides comprehensive research services and solutions for oncology and cancer-related drug development. The company offers a broad portfolio of services including cell therapy development, gene therapy, oncolytic virus research, and biomarker discovery. By leveraging advanced technologies in cytology and molecular biology, Alfa Cytology supports global pharmaceutical and biotechnology partners in accelerating their preclinical research programs. Their expertise spans across various therapeutic modalities, including CAR-T cells, monoclonal antibodies, and small molecules, aimed at addressing complex challenges in cancer treatment.